About Newronika
Newronika develops adaptive deep brain stimulation systems that respond to the brain's own signals. CE-marked αDBS therapy — precision neuromodulation for Parkinson's and beyond.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-B+
Global Headquarters
Cologno Monzese, Italy
Tracked Since
Oct 1, 2026
Web & Domain Identity
Official Website
newronika.com
Domain Registered Date
Jun 30, 2008
Social & Network Presence
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $15,880,000 · Series-B+
startupintros.com
- Milestone
X account created (@newronika)
90 followers
- Milestone
Website domain registered
newronika.com
Investors & Backers
ENEA Tech e Biomedical
European Innovation Council Fund
F3F
Indaco Venture Partners
Innogest Capital
TNBT Capital
Wille Finance
Funding History
Series-B+
· Feb 13, 2025
$15,880,000 startupintros.com
Founders & Leadership
Alberto Priori
Co-Founder, Scientific Advisory Board Chairman
Work email & phone locked
Unlock →
Lorenzo Rossi
Co-Founder, CEO & CTO
Work email & phone locked
Unlock →
Lothar Krinke
CEO
Work email & phone locked
Unlock →
Sara Marceglia
Co-Founder, Associate Professor
Work email & phone locked
Unlock →
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026